To assess the therapeutic potential of Vin in conjunction with an immune checkpoint inhibitor, we investigated the effects of an anti-PD-1 antibody combined with Vin in a B16F10 mouse tumor model (Fig. 6A). Here, LINC01191 is linked to neoplasm.